Free Trial
OTCMKTS:SNPHY

Santen Pharmaceutical (SNPHY) Stock Price, News & Analysis

$11.13 -0.17 (-1.50%)
As of 09/9/2025 03:34 PM Eastern

About Santen Pharmaceutical Stock (OTCMKTS:SNPHY)

Key Stats

Today's Range
$11.13
$11.69
50-Day Range
$10.03
$11.83
52-Week Range
$8.65
$13.00
Volume
813 shs
Average Volume
6,744 shs
Market Capitalization
N/A
P/E Ratio
0.11
Dividend Yield
433.95%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Santen Pharmaceutical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

SNPHY MarketRank™: 

Santen Pharmaceutical scored higher than 30% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Santen Pharmaceutical.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Santen Pharmaceutical is 0.11, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 278.34.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Santen Pharmaceutical is 0.11, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 75.69.

  • Read more about Santen Pharmaceutical's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Santen Pharmaceutical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Santen Pharmaceutical has recently decreased by 93.33%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Santen Pharmaceutical pays a meaningful dividend of 1.47%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Santen Pharmaceutical does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Santen Pharmaceutical is 46.34%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Santen Pharmaceutical's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Santen Pharmaceutical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Santen Pharmaceutical has recently decreased by 93.33%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Santen Pharmaceutical has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.
Receive SNPHY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Santen Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNPHY Stock News Headlines

GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.tc pixel
Santen Pharmaceutical Co (SNPHY) - Investing.com UK
Santen Pharmaceutical FY Net Y36.26B Vs Net Y26.64B
See More Headlines

SNPHY Stock Analysis - Frequently Asked Questions

Santen Pharmaceutical's stock was trading at $10.12 at the start of the year. Since then, SNPHY stock has increased by 10.0% and is now trading at $11.13.

Shares of SNPHY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/09/2025
Next Earnings (Estimated)
11/05/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
Current Symbol
OTCMKTS:SNPHY
CIK
1501108
Fax
N/A
Employees
4,144
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
0.11
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (OTCMKTS:SNPHY) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners